Book contents
- Perinatal Neuropathology
- Perinatal Neuropathology
- Copyright page
- Contents
- Preface
- Acknowledgments
- Abbreviations
- Section I Techniques and Practical Considerations
- Section 2 Human Nervous System Development
- Section 3 Stillbirth
- Section 4 Disruptions / Hypoxic-Ischemic Injury
- Section 5 Malformations
- Section 6 Perinatal Neurooncology
- Section 7 Spinal and Neuromuscular Disorders
- Arthrogryposis
- Spinal Muscular Atrophy
- Chapter 50 Spinal Muscular Atrophy (SMA)
- Early-Onset Hereditary Neuropathies
- Congenital Muscle Disorders
- Section 8 Eye Disorders
- Section 9 Infections: In Utero Infections
- Section 10 Metabolic / Toxic Disorders: Storage Diseases
- Section 11 Forensic Neuropathology
- Appendix 1 Technical Considerations in Perinatal CNS
- Index
- References
Chapter 50 - Spinal Muscular Atrophy (SMA)
from Spinal Muscular Atrophy
Published online by Cambridge University Press: 07 August 2021
Book contents
- Perinatal Neuropathology
- Perinatal Neuropathology
- Copyright page
- Contents
- Preface
- Acknowledgments
- Abbreviations
- Section I Techniques and Practical Considerations
- Section 2 Human Nervous System Development
- Section 3 Stillbirth
- Section 4 Disruptions / Hypoxic-Ischemic Injury
- Section 5 Malformations
- Section 6 Perinatal Neurooncology
- Section 7 Spinal and Neuromuscular Disorders
- Arthrogryposis
- Spinal Muscular Atrophy
- Chapter 50 Spinal Muscular Atrophy (SMA)
- Early-Onset Hereditary Neuropathies
- Congenital Muscle Disorders
- Section 8 Eye Disorders
- Section 9 Infections: In Utero Infections
- Section 10 Metabolic / Toxic Disorders: Storage Diseases
- Section 11 Forensic Neuropathology
- Appendix 1 Technical Considerations in Perinatal CNS
- Index
- References
Summary
Spinal muscular atrophy (SMA) refers to a group of progressive neurodegenerative conditions primarily involving spinal anterior horn cells, as well as select bulbar motor neurons. Onset may be in infancy, childhood, or teen years (historically classified into Types 1, 2, and 3; see Table 50.1). Adult-onset (type 4) SMA is not discussed further here.
- Type
- Chapter
- Information
- Perinatal Neuropathology , pp. 305 - 308Publisher: Cambridge University PressPrint publication year: 2021
References
Verhaart, IEC, Robertson, A, Wilson, IJ, Aartsma-Rus, A, Cameron, S, Jones, CC, Cook, SF, Lochmüller, H. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy – a literature review. Orphanet J Rare Dis 2017;12:124–39.CrossRefGoogle ScholarPubMed
Peeters, K, Chamova, T, Jordanova, A. Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies. Brain 2014; 137:2879–96.Google Scholar
Arnold, WD, Kassar, D, Kissel, JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015 51(2):157–67.CrossRefGoogle Scholar
Harding, BN. In: Developmental Neuropathology, 2nd edition, Adle-Biassette, H, Harding, BN, and Golden, JA, eds., John Wiley & Sons, 2018, pp. 469–75.Google Scholar
Prior, TW and Finanger, E. Spinal muscular atrophy. GeneReviews. Last updated December 22, 2016. www.ncbi.nlm.nih.gov/books/NBK1352/.Google Scholar
Darras, BT. Spinal muscular atrophies. Pediatr Clin North Am. 2015 62(3):743–66.CrossRefGoogle ScholarPubMed
Finkel, RS, Mercuri, E, Darras, BT, Connolly, AM, Kuntz, NL, Kirschner, J, Chiriboga, CA, Saito, K, Servais, L, Tizzano, E, Topaloglu, H, Tulinius, M, Montes, J, Glanzman, AM, Bishop, K, Zhong, ZJ, Gheuens, S, Bennett, CF, Schneider, E, Farwell, W, De Vivo, DC, ENDEAR Study Group.Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017 377(18):1723–32.CrossRefGoogle ScholarPubMed
Lowes, LP, Alfano, LN, Arnold, WD, Shell, R, Prior, TW, McColly, M, Lehman, KJ, Church, K, Sproule, DM, Nagendran, S, Menier, M, Feltner, DE, Wells, C, Kissel, JT, Al-Zaidy, S, Mendell, J. Impact of age and motor function in a phase 1/2a study of infants with SMA type 1 receiving single-dose gene replacement therapy. Pediatr Neurol. 2019;98:39–45.Google Scholar